Bioatla Inc (BCAB) is up Thursday morning, with the stock adding 4.65% in pre-market trading to 1.35. BCAB's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 135 out of 146 industries, Bioatla Inc ranks higher than 24% of stocks. Bioatla Inc has fallen 25.00% over the past month, closing at $1.79 on September 28. During this period of time, the stock fell as low as $1.34 and as high as $2.11. BCAB has an average analyst recommendation of Strong Buy. The company has an average price target of $15.83.
BCAB has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on BCAB!